InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Prout Samantha, Directeur Comptable Principal. Director active across 1 company, notably Amicus Therapeutics, INC.. Aggregated, 16 filings have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €555k. History available since 23 August 2021. The latest transaction was disclosed on 27 April 2026 (Disposition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Prout Samantha
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
125,951 shares@ US$14.500.039% mcap52.0% of flowCommon StockSEC:0001193125-26-182259:0
3,443 shares@ US$14.272.9% of flowCommon StockSEC:0001193125-26-005045:0
12,240 shares@ US$14.2710.3% of flowCommon StockSEC:0001193125-26-005045:1
32,193 shares0Common StockSEC:0001193125-25-307199:0
27,416 shares0Common StockSEC:0000950170-25-020043:0
3,443 shares@ US$9.312.2% of flowCommon StockSEC:0000950170-25-002428:0
7,027 shares@ US$10.664.9% of flowCommon StockSEC:0000950170-24-044881:0
30,767 shares@ US$14.002927.4% of flowCommon StockSEC:0000950170-24-003440:0
1,337 shares@ US$14.001.2% of flowCommon StockSEC:0000950170-24-003440:1
8,142 shares@ US$13.537.0% of flowCommon StockSEC:0000950170-24-002578:0
23,356 shares@ US$14.1920.8% of flowCommon StockSEC:0000950170-24-001295:0
7,659 shares@ US$14.00036.8% of flowCommon StockSEC:0000950170-23-073629:0
7,432 shares@ US$12.776.1% of flowCommon StockSEC:0001209191-23-046747:0
2,376 shares@ US$10.041.5% of flowCommon StockSEC:0001209191-23-045479:0
1,980 shares@ US$10.040.6% of flowCommon StockSEC:0001209191-21-055206:0
5,045 shares@ US$11.001.6% of flowCommon StockSEC:0001209191-21-053351:0
16 of 16 declarations
About Prout Samantha
Prout Samantha is Directeur Comptable Principal and Chief Accounting Officer at Amicus Therapeutics, INC. Their 16 filings span the period from 2021-08-25 to 2026-04-27, and across the sampled recent filings, sales total 2113180 EUR, with the dominant transaction nature listed as Retenue fiscale.
